Mikiko Tokiya
Overview
Explore the profile of Mikiko Tokiya including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
137
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ashenagar M, Hara M, Yamada G, Tokiya M, Matsumoto A
Vaccines (Basel)
. 2025 Jan;
12(12.
PMID: 39772021
Background/objectives: Although the protective effects of zinc against COVID-19 are documented, its impact on COVID-19 vaccine immunogenicity remains unknown. Methods: We conducted a prospective study involving a cohort of 79...
2.
Tokiya M, Hashimoto M, Fukuda K, Kawamoto K, Akao C, Tsuji M, et al.
Environ Health Prev Med
. 2024 Oct;
29:55.
PMID: 39401906
Background: The East Asian-specific genetic diversity, the rs671 variant of aldehyde dehydrogenase 2, causes the "Asian flush" phenomenon following alcohol consumption, resulting in an alcohol avoidance phenotype. The variant is...
3.
Bogahawaththa S, Hara M, Furukawa T, Iwasaka C, Sawada T, Yamada G, et al.
Vaccines (Basel)
. 2024 Sep;
12(9).
PMID: 39340045
We previously reported a reduced humoral immune response to the COVID-19 vaccines. Subsequently, we observed a lower susceptibility to COVID-19 in individuals carrying the rs671 variant through a web-based retrospective...
4.
Kobayashi T, Tokiya M, Matsumoto A, Nakano T, Hirota Y, Hara M
Front Public Health
. 2024 Mar;
12:1348170.
PMID: 38487189
Introduction: Addresing vaccine hesitancy is considered an important goal in management of the COVID-19 pandemic. We sought to understand what factors influenced people, especially those initially hesitant, to receive two...
5.
Itani O, Kaneita Y, Otsuka Y, Tokiya M, Jike M, Matsumoto Y, et al.
Sleep Biol Rhythms
. 2024 Mar;
20(1):53-63.
PMID: 38469066
This study aims to examine the relationship of sleep (sleep duration, sleep quality, and sleep rhythm) with presenteeism in workers while controlling for other confounding factors. A total of 2375...
6.
Takashima S, Tokiya M, Izui K, Miyamoto H, Matsumoto A
Environ Health Prev Med
. 2024 Mar;
29:14.
PMID: 38462476
Background: Coronavirus disease 2019 (COVID-19), first reported in December 2019, spread worldwide in a short period, resulting in numerous cases and associated deaths; however, the toll was relatively low in...
7.
Tokiya M, Kobayashi T, Kido M, Matsumoto A
Osteoporos Int
. 2023 Sep;
34(12):2133-2135.
PMID: 37695337
No abstract available.
8.
Sonoda R, Tokiya M, Touri K, Tanomura Y, Yada K, Funakoshi Y, et al.
Environ Health Prev Med
. 2023 Apr;
28:25.
PMID: 37081623
Background: A 4-year longitudinal study was conducted to develop a model and a point system for predicting childhood obesity. Methods: This study included 1,504 Japanese 10-year-old children who underwent health...
9.
Tokiya M, Hara M, Matsumoto A, Ashenagar M, Nakano T, Hirota Y
Vaccines (Basel)
. 2022 Jul;
10(7).
PMID: 35891266
The Japanese government approved COVID-19 vaccine booster doses in November 2021. However, intentions and readiness for booster vaccines among the general population were unknown. This survey measured the intentions for...
10.
Matsumoto A, Hara M, Ashenagar M, Tokiya M, Sawada T, Iwasaka C, et al.
Vaccines (Basel)
. 2022 Jul;
10(7).
PMID: 35891198
Uncovering the predictors of vaccine immunogenicity is essential for infection control. We have reported that the most prevalent polymorphism of the aldehyde dehydrogenase 2 gene (), rs671, may be associated...